gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NYSE · ABTHealthcarePharmaceuticals

Abbott Laboratories (ABT)

$115.51+5.58%
Close Nov 4, 2026 · split-adjusted
Oct 30, 2026$106.20▼ 14.09% in range
Oct 31, 2025Low $82.56 · High $130.59Oct 30, 2026
What changed · written from our data
As of Nov 4, 2026

Abbott Laboratories closed at $115.51 on Nov 4, up 5.58%, 11.5% below its 52-week closing high. Volume of 12.7M shares was 1.32× its 20-day average (above normal).

Split-adjusted performance: +17.7% over one month, +33.8% over six months, -6.7% over one year.

In the quarter ended Jun 30, 2026, revenue was $12.59B, up 13.0% from a year earlier, with a net margin of 7.4%.

Short interest was 17.4M shares at the Oct 15 settlement, up 27.5% from the prior report (1.0% of float, 1.8 days to cover).

Market cap$199.88B1.73B shares
Revenue · quarter$12.59B+13.0% YoY
Diluted EPS$0.53−47.5% YoY
P/E · TTM36.8×P/S 4.3×
Net margin7.4%Gross 57.7%
Dividend yield2.18%$0.63 last paid
52-week range82.56 – 130.59−11.5% from high
Volume12.7M1.32× 20-day avg
Volatility · 60d25.0%Annualised
Short % of float1.0%1.8 days to cover
Net cash-$27.00BCash $5.60B
Next earnings—Not scheduled
Split-adjusted performance
1W +12.5%1M +17.7%3M +7.0%6M +33.8%YTD −7.8%1Y −6.7%3Y +24.2%5Y −9.6%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum88
Revenue growth60
Net margin77
Value (low P/E)33
Size99

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →
Shares short17.4M+27.5% vs prior
Days to cover1.8Settled Oct 15
% of float1.0%
Short vol. 10d45.2%of daily volume

Closest peers by size in Pharmaceuticals

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
ABTAbbott Laboratories$115.51+5.58%+33.8%+13.0%7.4%36.8$199.88B
PFEPfizer$30.79+2.63%+16.1%+2.6%−1.6%40.5$175.49BCompare
VRTXVertex Pharmaceuticals$549.04+3.44%+28.4%+11.8%19.0%35.0$139.16BCompare
BMYBristol-Myers Squibb$64.19+4.02%+13.4%+5.7%25.6%14.1$131.21BCompare
MRKMerck & Co.$150.36+3.93%+32.4%+5.1%−8.0%116.9$370.96BCompare
REGNRegeneron Pharmaceuticals$930.67−4.39%+29.1%+36.3%38.1%20.0$96.28BCompare
ABBVABBVIE$294.83+3.09%+43.8%+10.3%24.2%50.4$521.00BCompare
JNJJohnson & Johnson$276.32+3.81%+23.0%+5.9%0.8%41.3$665.19BCompare
TEVATeva Pharmaceutical Industries Limited$41.85−0.14%+15.2%−0.8%−13.9%69.0$48.81BCompare

News about Abbott Laboratories

All news →
Is Most-Watched Stock Abbott Laboratories (ABT) Worth Betting on Now?Zacks Investment Research · Oct 27, 2026▼ NegativeThis Dividend King Just Announced Great News for InvestorsThe Motley Fool · Oct 26, 2026▲ PositiveAbbott Laboratories vs. UnitedHealth: Does Health Innovation or Health Insurance Make for a Better Stock to Buy?The Motley Fool · Oct 24, 2026▲ PositiveCatheter Precision Announces Publication of Comparative Study Showing LockeT Outperforms Abbott’s Perclose Internal Vascular Closure DeviceGlobeNewswire Inc. · Oct 22, 2026▼ NegativeAbbott: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · Oct 21, 2026▲ Positive

Quick answers

What does Abbott Laboratories do?
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment.
What is ABT's market cap?
$199.88B, based on the Nov 4 close of $115.51.
What is ABT's P/E ratio?
36.8× trailing-twelve-month earnings of $5.42B.
Does Abbott Laboratories pay a dividend?
Yes. The latest regular dividend was $0.63 per share (ex-date Oct 15), an annualised yield of 2.18%.
How much of ABT is sold short?
17.4M shares, 1.0% of float, as of Oct 15, 2026.
What sector is ABT in?
Healthcare, in the Pharmaceuticals industry.

About Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

HQ: Abbott Park, IL115,000 employeesListed Apr 19, 1949abbott.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology